Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8705 |
High Similarity |
NPD7266 |
Discontinued |
0.8676 |
High Similarity |
NPD1613 |
Approved |
0.8676 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8621 |
High Similarity |
NPD1653 |
Approved |
0.8593 |
High Similarity |
NPD3027 |
Phase 3 |
0.8382 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8309 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8146 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8014 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7974 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7887 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7875 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7853 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7846 |
Intermediate Similarity |
NPD228 |
Approved |
0.784 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7826 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7823 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7761 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7742 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7733 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7683 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7676 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7664 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7632 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7609 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7603 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7603 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7595 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7594 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7584 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7564 |
Intermediate Similarity |
NPD37 |
Approved |
0.7562 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7551 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7548 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7538 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7534 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7519 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7481 |
Intermediate Similarity |
NPD2684 |
Approved |
0.747 |
Intermediate Similarity |
NPD7038 |
Approved |
0.747 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7467 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7466 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD5763 |
Approved |
0.745 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7448 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7447 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7432 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7413 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7405 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7388 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7383 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7357 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7355 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7328 |
Intermediate Similarity |
NPD968 |
Approved |
0.7319 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7293 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7292 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7273 |
Intermediate Similarity |
NPD290 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7214 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7203 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7183 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7176 |
Intermediate Similarity |
NPD8313 |
Approved |
0.717 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7169 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD291 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7105 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD17 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7086
|
Intermediate Similarity |
NPD1510 |
Phase 2 |